Navigation Links
InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
Date:11/7/2012

securing coverage from private insurance plans and reimbursement from public (provincial) drug reimbursement plans in Canada; and (vii) InterMune's ability to obtain or maintain patent or other proprietary intellectual property protections.  The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K, Form 10-Q and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at www.intermune.com.Esbriet® is a registered trademark of InterMune, Inc. 

Financial tables follow:InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited, in thousands, except per share amounts)Three Months EndedNine Months EndedSeptember 30,September 30,2012201120122011Revenue, net  Esbriet

$

7,534$

118

$

17,952$

118  Collaboration revenue-0-2,629Total revenue, net7,53411817,9522,747Costs and expenses:  Cost of goods sold2,0173856,200385  Research and development26,17517,04574,55353,967  Selling, general and administrative23,75423,65275,68062,661Total costs and expenses51,94641,082156,433117,013Loss from operations(44,412)(40,964)(138,481)(114,266)Interest income148131452390Interest expense(2,031)(1,281)(6,473)(4,154)Other income (expense)975(227)(149)(322)Loss from operations before income taxes(45,320)(42,341)(144,651)(118,352)Income tax expense192-326-Loss from continuing operations (45,512)(42,341)(144,977)(118,352)Discontinued operations:Income from discontinued operations1324,0972,1258,111Gain on sale of discontinued operations--51,335-Income from discontinued operations1324,09753,4608,111Net loss

$

(45,380)$

(38,244)

$

(91,517)$

(110,241)Basic and diluted net income (loss) per common share:Continu
'/>"/>

SOURCE InterMune, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune To Release Third Quarter Financial Results On November 7
2. InterMune To Present At JMP Securities Healthcare Conference
3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
4. InterMune to Present at J. P. Morgan Healthcare Conference
5. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
6. PharmAthene Reports Third Quarter 2012 Financial Results
7. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
8. Patient Safety Technologies Reports Third Quarter 2012 Results
9. PDI Reports 2012 Third Quarter Financial Results
10. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
11. Neurocrine Biosciences Reports Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Ardelyx, ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... quarter 2014 financial results on Thursday, November 6, ... will host a live conference call and webcast ... results and provide a business update. ...
(Date:10/30/2014)... Rancho BioSciences , the scientific ... curated public data source TCGA for several ... data is now available for other oncology groups. ... internal data sources for their Pharma, Government and academic ... data that becomes more easily accessible. Rancho advises ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Grace Century portfolio ... James A. Manganello, Chairman of the Board, to the ... The appointment was made by the Ministry of Health ... 24th, 2014. , More than a year after ... Bill , Prime Minister Perry Christie said the government has ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3CU Denver study says upgrading infrastructure could reduce flood damage 2
... 20 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... Inc. (Ibis), has been awarded four new,government contracts ... detection,and identification of microbial threat agents for biodefense ... of Homeland Security,Science and Technology Directorate (DHS-S&T) and ...
... Retrieving material for composting from open dumps across the ... mountains of waste, according to researchers in India, writing ... Technology and Management. , These days we in the ... kitchen waste. However, not everyone has a compost bin ...
... Coulter,Inc. (NYSE: BEC ), a leading developer, ... innovate complex biomedical testing,announced today that Charles Slacik, ... will present at the 2007 UBS Global,Life Sciences ... p.m.,(EDT). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The ...
Cached Biology Technology:Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4Landfill mining reduces environmental impact of growing waste 2Beckman Coulter to Present at the UBS Global Life Sciences Conference 2
(Date:10/28/2014)... awards to expand the Office of Rare Diseases ... Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical Research ... at 22 consortia will work with 98 patient ... new treatments for patients with rare diseases. The ... fiscal 2014 funding from NIH. , Rett syndrome, ...
(Date:10/27/2014)... a scientific one-two punch with a pair of papers ... sticky ends. , Collagen is the most common protein ... fibrous tissues that support cells and hold organs together. ... for tissue engineering and cosmetic and reconstructive medicine. , ... synthetic collagen for a decade, teasing out the details ...
(Date:10/27/2014)... Recent breakthroughs may pave the way for vaccines ... helminths. These flatworms, including tapeworms that cause hydatid ... (schistosomes), infect more than 300 million people and ... due to chronic illness and death each year. ... microbiology, immunology, and tropical medicine, and scientific director ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3GW researcher adapting breakthrough technologies to combat parasitic worm infections 2
... of hatchery-raised young salmonids are released into Swedish rivers ... Butthese fish generally survive poorly in the wild. Researchers ... young fish get too crowded at the hatchery. ... million euro to a Swedish/Nordic research project. The goal ...
... of University of Kansas researchers working with Chinese colleagues have ... years ago in China. This is the first report of ... "This thing is a venomous bird for all intents and ... paleontology at the Natural History Museum and Biodiversity Institute. "It ...
... drug-resistant form of the deadly H5N1 avian influenza is a nightmare ... study published this week (Dec. 21) in the Proceedings of ... a new compound, one on the threshold of final testing in ... than the antiviral drug best known by the trade name Tamiflu. ...
Cached Biology News:Hatchery-raised salmon too crowded 2Poisonous prehistoric 'raptor' discovered by research team from Kansas and China 2Compound found to safely counter deadly bird flu 2